(Q33962266)

30 July 2017

1 reference

title

Genotype and viral load as prognostic indicators in the treatment of hepatitis C. (English)

1 reference

30 July 2017

1 reference

Trepo C

1

1 reference

30 July 2017

publication date

1 July 2000

1 reference

Journal of Viral Hepatitis

30 July 2017

published in

1 reference

30 July 2017

volume

7

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

250-257

1 reference

A practical guide to the use of interferons in the management of hepatitis virus infections

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Comparison of HCV RNA levels by branched DNA probe assay and by competitive polymerase chain reaction to predict effectiveness of interferon treatment for patients with chronic hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Genetic organization and diversity of the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Hepatitis C virus updated

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

At least five related, but distinct, hepatitis C viral genotypes exist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Analysis of genomic variability of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Detection of three types of hepatitis C virus in blood donors: investigation of type‐specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

A new type of hepatitis C virus in patients in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Quantitative measurement of HCV RNA in the serum: a comparison of three assays based on different principles

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Usefulness of HCV-RNA assays in efficacy evaluation of interferon treatment for chronic hepatitis C: Amplicor HCV assay and branched DNA probe assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Differences in the hepatitis C virus genotypes in different countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Prevalence of hepatitis C virus sequence variants in South-East Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Molecular epidemiology of hepatitis C in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Unexpected high prevalence of hepatitis C virus genotype 4 in Southern Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Distribution of the different subtypes of hepatitis C virus in Japan and the effects of interferon: a nationwide survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Hepatitis C virus 1b is the dominant genotype in HCV-related carcinogenesis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Influence of pre-treatment factors on outcome of interferon-alpha treatment of patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: a multicenter randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Clinical backgrounds of the patients having different types of hepatitis C virus genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Factors predictive of a beneficial response to therapy of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Differential sensitivity of hepatitis C virus quasispecies to interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Comparison of 3 quantitative HCV RNA assays--accuracy of baseline viral load to predict treatment outcome in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Earlier loss of hepatitis C virus RNA in interferon therapy can predict a long-term response in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2000.00233.X

10.1046/J.1365-2893.2000.00233.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference